Pregnancy and COVID-19, focus on vaccine and pharmacological treatment
- 21 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 151, 103630
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionalsUltrasound in Obstetrics & Gynecology, 2020
- What are the risks of COVID-19 infection in pregnant women?The Lancet, 2020
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical recordsThe Lancet, 2020
- Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus InfectionsViruses, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- A novel coronavirus outbreak of global health concernThe Lancet, 2020
- The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying MechanismsFrontiers in Immunology, 2018
- The Safety of Low-Molecular-Weight Heparin During and After PregnancyObstetrical & Gynecological Survey, 2017
- Use of colchicine in pregnancy: a systematic review and meta-analysisRheumatology, 2017
- Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing dataSeminars in Arthritis and Rheumatism, 2016